X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs DR. REDDYS LAB - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA DR. REDDYS LAB FULFORD INDIA/
DR. REDDYS LAB
 
P/E (TTM) x 398.8 34.5 1,157.4% View Chart
P/BV x 6.2 3.4 184.1% View Chart
Dividend Yield % 0.1 0.8 10.6%  

Financials

 FULFORD INDIA   DR. REDDYS LAB
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
DR. REDDYS LAB
Mar-17
FULFORD INDIA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs9423,397 27.7%   
Low Rs4502,560 17.6%   
Sales per share (Unadj.) Rs691.4856.5 80.7%  
Earnings per share (Unadj.) Rs11.578.0 14.7%  
Cash flow per share (Unadj.) Rs15.4139.9 11.0%  
Dividends per share (Unadj.) Rs2.0020.00 10.0%  
Dividend yield (eoy) %0.30.7 42.8%  
Book value per share (Unadj.) Rs380.0739.8 51.4%  
Shares outstanding (eoy) m3.90165.74 2.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x1.03.5 29.0%   
Avg P/E ratio x60.738.2 158.9%  
P/CF ratio (eoy) x45.321.3 212.9%  
Price / Book Value ratio x1.84.0 45.5%  
Dividend payout %17.425.7 68.0%   
Avg Mkt Cap Rs m2,714493,632 0.5%   
No. of employees `0000.422.7 2.0%   
Total wages/salary Rs m50531,068 1.6%   
Avg. sales/employee Rs Th6,073.06,259.0 97.0%   
Avg. wages/employee Rs Th1,137.41,369.8 83.0%   
Avg. net profit/employee Rs Th100.7569.7 17.7%   
INCOME DATA
Net Sales Rs m2,696141,961 1.9%  
Other income Rs m1251,715 7.3%   
Total revenues Rs m2,822143,676 2.0%   
Gross profit Rs m-4624,722 -0.2%  
Depreciation Rs m1510,266 0.1%   
Interest Rs m10634 1.5%   
Profit before tax Rs m5415,537 0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m0349 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m102,965 0.3%   
Profit after tax Rs m4512,921 0.3%  
Gross profit margin %-1.717.4 -9.9%  
Effective tax rate %17.719.1 92.6%   
Net profit margin %1.79.1 18.2%  
BALANCE SHEET DATA
Current assets Rs m1,73896,837 1.8%   
Current liabilities Rs m54584,199 0.6%   
Net working cap to sales %44.38.9 497.2%  
Current ratio x3.21.2 277.5%  
Inventory Days Days4873 66.1%  
Debtors Days Days498 4.4%  
Net fixed assets Rs m12102,552 0.0%   
Share capital Rs m39829 4.7%   
"Free" reserves Rs m1,443121,792 1.2%   
Net worth Rs m1,482122,621 1.2%   
Long term debt Rs m05,449 0.0%   
Total assets Rs m2,077218,165 1.0%  
Interest coverage x6.725.5 26.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.7 199.5%   
Return on assets %2.66.2 42.0%  
Return on equity %3.010.5 28.6%  
Return on capital %4.312.9 33.4%  
Exports to sales %054.6 0.0%   
Imports to sales %24.59.4 261.5%   
Exports (fob) Rs mNA77,520 0.0%   
Imports (cif) Rs m65913,274 5.0%   
Fx inflow Rs m1781,670 0.0%   
Fx outflow Rs m67326,355 2.6%   
Net fx Rs m-65655,315 -1.2%   
CASH FLOW
From Operations Rs m9021,444 0.4%  
From Investments Rs m105-18,404 -0.6%  
From Financial Activity Rs m-14-3,692 0.4%  
Net Cashflow Rs m181-1,144 -15.8%  

Share Holding

Indian Promoters % 0.0 25.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 5.4 70.4%  
FIIs % 0.1 35.3 0.3%  
ADR/GDR % 0.0 18.5 -  
Free float % 21.2 15.3 138.6%  
Shareholders   4,783 75,885 6.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   WYETH LTD  IPCA LABS  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  PIRAMAL ENTERPRISES  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and banking sector witnessing maximum buying interest.

Related Views on News

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Is it Wise to Ignore Bitcoins?(The 5 Minute Wrapup)

Jan 4, 2018

While investing in bitcoins, it would make sense to treat it as another asset class and decide accordingly.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA - TTK HEALTHCARE COMPARISON

COMPARE FULFORD INDIA WITH

MARKET STATS